Drug Profile
Pregabalin sustained release - Jiangsu HengRui Medicine
Alternative Names: EASOPSRTFP; Pregabalin - Jiangsu HengRui MedicineLatest Information Update: 16 Mar 2022
Price :
$50
*
At a glance
- Originator Jiangsu Hengrui Medicine Co.
- Class Aminobutyric acids; Analgesics; Antiepileptic drugs; Anxiolytics; Gabapentinoids; Neuroprotectants; Small molecules
- Mechanism of Action CACNA2D1 protein modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Fibromyalgia; Postherpetic neuralgia
Most Recent Events
- 18 Feb 2022 Discontinued - Phase-III for Fibromyalgia in China (PO) (Jiangsu HengRui Medicine pipeline, February 2022)
- 18 Feb 2022 Discontinued - Phase-III for Postherpetic neuralgia in China (PO) (Jiangsu HengRui Medicine pipeline, February 2022)
- 29 Jan 2019 Chemical structure information added